IBM’s Retreat From Watson Highlights Broader AI Struggles in Well being

Ten years in the past, Worldwide Enterprise Machine Corp.’s synthetic intelligence system Watson bested people on the quiz present “Jeopardy!”

The feat was imagined to herald a shift in the way in which machines served up solutions to questions large and small, opening up new income streams for Massive Blue particularly and Massive Tech extra usually. A key goal: healthcare, a trillion-dollar business many say is saddled with inefficiencies that some tech advocates say AI may treatment.

A decade later, actuality has fallen in need of that promise. IBM is now exploring the sale of Watson Well being, a unit whose marquee product was supposed to assist medical doctors diagnose and treatment most cancers.

IBM spent a number of billion {dollars} on acquisitions to construct up Watson. Former senior IBM govt John Kelly as soon as touted the initiative as a “guess the ranch” transfer. It didn’t dwell as much as the hype. Watson Well being has struggled for market share within the U.S. and overseas and at present isn’t worthwhile.

Alphabet Inc.’s Google DeepMind unit, which famously developed a Go-playing algorithm that vanquished a champion human participant in 2016, later launched a number of healthcare-related initiatives targeted on persistent circumstances. It additionally has misplaced cash in recent times and run into privateness issues over how well being knowledge was being collected.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.